Filing Flows › United States Antimony (UAMY) › Q2 2026 › vs Q2 2025
United States Antimony (UAMY) Q2 2026 vs Q2 2025 (year over year)
United States Antimony's revenue fell $2.6M (-25%) from $10.5M in Q2 2025 to $7.9M in Q2 2026. The biggest changes: Antimony −$3.8M (-39%); Zeolite +$973K (+110%).
United States Antimony, Q2 2026: revenue $7.9M (-25% year over year), operating margin -88.1%, net earnings $110K, operating cash flow −$8.7M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Antimony | $5.9M | $9.6M | −$3.8M | -39% |
| Zeolite | $1.9M | $888K | $973K | +110% |
| Revenue | $7.9M | $10.5M | −$2.6M | -25% |
| Other income, net | $7.1M | $162K | $6.9M | 44× |
| Costs & expenses | $15.0M | $10.7M | $4.3M | +41% |
| Operating costs | $14.9M | $10.5M | $4.4M | +42% |
| Net earnings | $110K | $182K | −$71K | -39% |
| Cost of revenue | $7.3M | $7.7M | −$345K | -4% |
| General & admin | $1.6M | $843K | $767K | +91% |
| Other operating costs | $6.0M | $2.0M | $4.0M | +202% |
| Operating cash sources | $12.2M | $1.7M | $10.5M | +628% |
| Depreciation & amortization | $515K | $278K | $238K | +86% |
| Share-based compensation | $2.9M | $587K | $2.3M | +395% |
| Cash used in operations | $8.7M | $628K | $8.0M | 14× |
| Working capital & other | $12.2M | $1.7M | $10.5M | +628% |
Questions
How much did United States Antimony's revenue grow year over year in Q2 2026?
United States Antimony's revenue fell $2.6M (-25%) from $10.5M in Q2 2025 to $7.9M in Q2 2026.
What drove United States Antimony's revenue change in Q2 2026?
Antimony −$3.8M (-39%); Zeolite +$973K (+110%).